Townsend Claire L, Cortina-Borja Mario, Peckham Catherine S, de Ruiter Annemiek, Lyall Hermione, Tookey Pat A
MRC Centre of Epidemiology for Child Health, UCL Institute of Child Health, University College London, London, UK.
AIDS. 2008 May 11;22(8):973-81. doi: 10.1097/QAD.0b013e3282f9b67a.
In the United Kingdom (UK) and Ireland, avoidance of breastfeeding and alternative combinations of antiretroviral therapy regimen and mode of delivery are recommended according to maternal clinical status. The aim of this analysis was to explore the impact of different strategies to prevent mother-to-child transmission at a population level.
Comprehensive national surveillance study.
Pregnancies in diagnosed HIV-infected women in the UK and Ireland are notified to the National Study of HIV in Pregnancy and Childhood; infant infection status is subsequently reported. Factors associated with transmission in this observational study were explored for singleton births between 2000 and 2006.
The overall mother-to-child transmission rate was 1.2% (61/5151, 95% confidence interval: 0.9-1.5%), and 0.8% (40/4864) for women who received at least 14 days of antiretroviral therapy. Transmission rates following combinations recommended in British guidelines were 0.7% (17/2286) for highly active antiretroviral therapy with planned Caesarean section, 0.7% (4/559) for highly active antiretroviral therapy with planned vaginal delivery, and 0% (0/464) for zidovudine monotherapy with planned Caesarean section (P = 0.150). Longer duration of highly active antiretroviral therapy was associated with reduced transmission after adjusting for viral load, mode of delivery and sex (adjusted odds ratio = 0.90 per week of highly active antiretroviral therapy, P = 0.007). Among 2117 infants born to women on highly active antiretroviral therapy with viral load less than 50 copies/ml, only three (0.1%) were infected, two with evidence of in-utero transmission.
Sustained low HIV transmission rates following different combinations of interventions in this large unselected population are encouraging. Current options for treatment and delivery offered to pregnant women according to British guidelines appear to be effective.
在英国和爱尔兰,建议根据母亲的临床状况避免母乳喂养,并采用抗逆转录病毒治疗方案和分娩方式的替代组合。本分析的目的是在人群层面探讨不同预防母婴传播策略的影响。
全国性综合监测研究。
英国和爱尔兰确诊感染艾滋病毒的孕妇的妊娠情况会上报给全国妊娠与儿童期艾滋病毒研究;随后报告婴儿的感染状况。对2000年至2006年期间单胎分娩进行观察性研究,探讨与传播相关的因素。
总体母婴传播率为1.2%(61/5151,95%置信区间:0.9 - 1.5%),接受至少14天抗逆转录病毒治疗的女性的传播率为0.8%(40/4864)。按照英国指南推荐的组合,接受高效抗逆转录病毒治疗并计划剖宫产的传播率为0.7%(17/2286),接受高效抗逆转录病毒治疗并计划阴道分娩的传播率为0.7%(4/559),接受齐多夫定单药治疗并计划剖宫产的传播率为0%(0/464)(P = 0.150)。在调整病毒载量、分娩方式和性别后,高效抗逆转录病毒治疗时间越长,传播率越低(高效抗逆转录病毒治疗每增加一周,调整后的优势比 = 0.90,P = 0.007)。在病毒载量低于50拷贝/ml且接受高效抗逆转录病毒治疗的女性所生的2117名婴儿中,只有3名(0.1%)被感染,其中2名有宫内传播的证据。
在这个未经过筛选的大型人群中,不同干预措施组合后持续保持低艾滋病毒传播率令人鼓舞。按照英国指南为孕妇提供的当前治疗和分娩选择似乎是有效的。